Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Individualized Testosterone Protocol for Transgender Acne

Publish date:: April 29, 2019

Key clinical point: Look for serum testosterone higher than 630 ng/dL.

Major finding: By month 24, 38% of patients experienced acne.

Study details: A study of 55 female-to-male transgender patients receiving masculinizing doses of testosterone.

Disclosures: The study was funded by a summer research program at Boston University. The authors had no conflicts of interest to report.

Citation:

Park JA et al. J Am Acad Dermatol. 2019. doi: 10.1016/j.jaad.2018.12.040.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Dermatology

Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases,

Study results support screening rosacea patients for cardiometabolic disease,

Phase 1 study: Beta-blocker may improve melanoma treatment response,

Baricitinib reduces adult atopic dermatitis severity in phase 3 study,

New lupus classification criteria perform well in children, young adults,